. RPE cells were better visualized using AO-ICG (top row) compared to darkfield (bottom row). Each column represents a different eye (subject number indicated in top left corner). In our hands, darkfield has a low success rate for visualizing RPE. Scale bar, 50 µm.
Supplementary Figure 4.
Effect of optical sectioning on AO-ICGA images of inner retinal vessels (subject 5 from Supplementary Table 2 ). There was substantial out-of-focus fluorescent light originating from the underlying RPE in AO-ICG images acquired with (a) a large confocal aperture (weak rejection of out-of-focus light) compared to (b) a small confocal aperture (strong rejection of out-of-focus light). Images in (a) and (b) were taken 3 months apart with a repeat injection of ICG. (c-e) Zooms of overlapping area (white box) in (a) and (b). (c) Late phase AO-ICG image of RPE from visit 1. (d) There are some changes in the RPE pattern between the early (d) and late (c) phase, but the overall out-offocus fluorescent pattern corresponding to the RPE can be seen (e.g. white arrow). (e) The out of focus light is significantly reduced using a smaller confocal aperture. This data also confirms that the signal that we are observing arises from the outer retina and is not the result of out of focus light from the inner retina. All scale bars, 100 µm. Figure 5 . Images of choroidal vessels at additional non-foveal locations (approximate retinal eccentricity: 4.5 mm temporal). The subject code is indicated in the bottom left corner. By changing the focus to a deeper layer beneath the choriocapillaris, it was possible to see larger choroidal vessels (subject 23). Out of focus light from the larger choroidal vessels can also been seen while focused at the choriocapillaris (subject 8). Scale bar, 100 µm. Figure 6 . AO-ICG fluorescence intensity time plot. Data from single push subjects as well as from the third push of three push (1+1+1) subjects are shown (subject number indicated in bottom right corner). The recirculation times measured are show in the top right corner. Some were not measurable as described in the text. Scale bar, 20 seconds. # = subject with healthy eye, RP = patient with retinitis pigmentosa. 2 ICG dose (25 mg in 3 mL), given in one push (3 mL), two pushes (1 mL followed by 2 mL), or three pushes (1 mL each). 
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